Medica Pharmaceutical Industries L Pharmaceutical Import Profile — Yemen (DGFT 2022–2026)

Name: Medica Pharmaceutical Industries L Pharmaceutical Import Records from India — 2 Products, $264.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Medica Pharmaceutical Industries L — Pharmaceutical Importer Profile (2026) | 2 Products, $264.8K Trade | TransData Nexus

Medica Pharmaceutical Industries L

Pharmaceutical Importer · Yemen · Combination Drugs Focus · $264.8K Total Trade · DGFT Verified

Medica Pharmaceutical Industries L is a pharmaceutical importer based in Yemen with a total trade value of $264.8K across 2 products in 2 therapeutic categories. Based on 7 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Medica Pharmaceutical Industries L sources from 1 verified Indian supplier, with Cipla Limited accounting for 100.0% of imports.

Medica Pharmaceutical Industries L — Import Portfolio & Supplier Network

Medica Pharmaceutical Industries L import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Medica Pharmaceutical Industries L?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Cipla Limited	$4.9M	340	100.0%

Medica Pharmaceutical Industries L sources from 1 verified Indian supplier across 174 distinct formulations. The sourcing is highly concentrated — Cipla Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Medica Pharmaceutical Industries L Import?

Formulation	Value	Ships
Lomac 20 capsules (omeprazole 20 MG) inv.qty.16380 Pack 30x10's=4914000	$170.1K	9
Urisoda granules sachets (sodium bicarbonate 44.03%+sodium citrate anh. 15.75%+ tartaric acid 22.25%+citric	$169.0K	16
Amlopres 10 tablet (amlodipine besilate 10 MG) (inv.qty. 4573 Pack 10x10's=457300 nos)	$164.7K	4
Amlopres 10 tablet (amlodipine besilate 10 MG) (inv.qty. 4103 Pack 10x10's=410300 nos)	$147.7K	4
Alfacip 0.25 MCG capsules (alfacalcidol soft gelatin capsules 0.25mcg) (inv.qty. 6832 Pack 7x10's=478240 nos)	$137.8K	4
Alfacip 0.25 MCG capsules (alfacalcidol soft gelatin capsules 0.25mcg) (inv.qty. 6674 Pack 7x10's=467180 nos)	$134.6K	4
Lomac 20 capsules (omeprazole 20 MG) inv.qty.16400 Pack 30x10's=4920000	$113.6K	6
Foracort 100 rotacaps (formoterol fumarate dihydrate 6 MG + budesonide 100 MCG) (inv.qty. 32381 Pack	$100.0K	2
Serocip 300MG tablets (quetiapine fumarate 300MG) ( inv. qty. 2810 Pack 10 x 10's = 281000 nos )	$100.0K	2
Amlopres 10 tablet (inv.qty. 4573 Pack 10x10's=457300 nos)	$82.8K	2
Amlopres 10 tablet (inv.qty. 4103 Pack 10x10's=410300 nos)	$74.3K	2
Alfacip 0.25 MCG capsules (inv.qty. 6832 Pack 7x10's=478240 nos)	$69.3K	2
Alfacip 0.25 MCG capsules (inv.qty. 6674 Pack 7x10's=467180 nos)	$67.7K	2
Lomac 20 capsules (omeprazole 20 MG) inv.qty. 16396 Pack 30 x 10's =4918800	$56.8K	3
Lomac 20 capsules (omeprazole 20 MG) inv.qty.16392 Pack 30x10's=4917600	$56.8K	3

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Salicylic	Combination Drugs	$167.3K	4	1.0%	18
2	Torsemide	Diuretics	$97.5K	3	0.5%	17

Medica Pharmaceutical Industries L imports 2 pharmaceutical products across 2 categories into Yemen totaling $264.8K.

Medica Pharmaceutical Industries L — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Medica Pharmaceutical Industries L is a prominent pharmaceutical company based in Yemen, specializing in the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company is headquartered in Matna-Bani Mattar, Sana'a, Yemen, and operates a state-of-the-art manufacturing facility constructed in 2014, covering 36,000 square meters. This facility is designed to meet internationally recognized quality standards and is built with future expansion in mind.

Medica Pharmaceutical Industries L plays a pivotal role in Yemen's pharmaceutical distribution network, ensuring the availability of essential medications across the country. The company's mission is to deliver high-quality, accessible, and innovative pharmaceutical solutions that enhance the health and well-being of the communities it serves.

2Distribution Network

While specific details about Medica Pharmaceutical Industries L's warehouse locations and logistics capabilities are not publicly disclosed, the company's extensive import activities suggest a well-established distribution network. The manufacturing facility in Sana'a serves as a central hub for operations, likely coordinating the importation, storage, and distribution of pharmaceutical products throughout Yemen. Given the strategic location of the facility and the company's commitment to quality and accessibility, it is reasonable to infer that Medica Pharmaceutical Industries L has a comprehensive distribution network covering major cities and regions within Yemen.

3Industry Role

Medica Pharmaceutical Industries L serves as a primary wholesaler and importer in Yemen's pharmaceutical supply chain. By importing finished pharmaceutical formulations from international suppliers, the company ensures a steady supply of essential medications to meet the healthcare needs of the Yemeni population. Its role is crucial in bridging the gap between global pharmaceutical manufacturers and local healthcare providers, facilitating the availability of a diverse range of pharmaceutical products across the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Medica Pharmaceutical Industries L

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Medica Pharmaceutical Industries L demonstrates a high degree of supplier concentration, sourcing all its pharmaceutical imports from a single supplier, CIPLA LIMITED. This exclusive sourcing strategy indicates a strategic partnership, potentially offering benefits such as favorable pricing, consistent product quality, and reliable supply chain management. However, this single-source dependency also poses risks, including vulnerability to supply disruptions or changes in supplier terms. The stability of this relationship is evidenced by the consistent importation of 173 shipments from CIPLA LIMITED, reflecting a stable and ongoing partnership.

2Supply Chain Resilience

The resilience of Medica Pharmaceutical Industries L's supply chain is closely tied to its exclusive relationship with CIPLA LIMITED. While this partnership offers stability, it also means that the company has limited exposure to alternative suppliers, which could be a concern in the event of supply chain disruptions. The company's focus on importing finished pharmaceutical formulations suggests a reliance on suppliers with robust manufacturing capabilities and adherence to international quality standards. CIPLA LIMITED, as a reputable supplier, is expected to comply with regulatory requirements and maintain consistent product quality, contributing to the overall resilience of the supply chain.

Importing Pharmaceuticals into Yemen — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Yemen

1Regulatory Authority & Framework

The Supreme Authority for Medicines and Medical Appliances (SAMA) is the primary regulatory body overseeing pharmaceutical imports in Yemen. SAMA is responsible for ensuring that all imported pharmaceutical products meet the country's safety, efficacy, and quality standards. Key legislation governing pharmaceutical imports includes Law No. 5 of 2020, which exempts production inputs for pharmaceutical manufacturing from customs duties, thereby facilitating the importation of essential medical supplies. The marketing authorization pathway for Indian generics involves obtaining approval from SAMA, which requires compliance with specific regulatory standards and submission of necessary documentation to ensure product quality and safety.

2Import Licensing & GMP

Import licensing requirements in Yemen necessitate that pharmaceutical importers, such as Medica Pharmaceutical Industries L, register with the Ministry of Industry and Trade and obtain an import license specific to pharmaceutical products. Additionally, compliance with Good Manufacturing Practices (GMP) is mandatory. GMP certificates from recognized authorities, such as the European Union (EU) GMP, World Health Organization (WHO) GMP, or Pharmaceutical Inspection Co-operation Scheme (PIC/S), are typically recognized by Yemeni authorities. Importers must ensure that their suppliers adhere to these standards to facilitate the importation process. Wholesale distribution authorization is also required, ensuring that companies like Medica Pharmaceutical Industries L operate within the legal framework established by Yemeni regulatory bodies.

Medica Pharmaceutical Industries L — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Medica Pharmaceutical Industries L's focus on importing combination drugs and diuretics aligns with the therapeutic needs prevalent in Yemen. Combination drugs, which account for 63.2% of imports, are essential for treating complex conditions requiring multiple therapeutic agents. Diuretics, comprising 36.8% of imports, are commonly used to manage hypertension and edema, conditions with high incidence rates in the region. The market demand for these products is driven by the need for effective treatments for cardiovascular and renal conditions, necessitating a reliable supply of these medications.

2Sourcing Profile

Medica Pharmaceutical Industries L's sourcing strategy is centered on importing generic drugs, primarily in the form of finished pharmaceutical formulations. The company's preference for sourcing from India, particularly from CIPLA LIMITED, reflects a strategic choice to leverage cost-effective and high-quality generics. This approach enables the company to offer affordable medications to the Yemeni market while maintaining product quality and compliance with regulatory standards.

3Market Positioning

Seller's Guide — How to Become a Supplier to Medica Pharmaceutical Industries L

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Medica Pharmaceutical Industries L, given the company's exclusive sourcing relationship with CIPLA LIMITED. Potential suppliers can explore gaps in the current product offerings, such as introducing new therapeutic categories or formulations not currently imported. Additionally, suppliers can focus on providing competitive pricing, consistent product quality, and reliable supply chain management to meet the evolving needs of the Yemeni market.

2Requirements & Qualifications

Indian exporters seeking to supply Medica Pharmaceutical Industries L and the Yemeni market must ensure compliance with Yemeni import regulations, including obtaining the necessary import licenses and adhering to GMP standards recognized by Yemeni authorities. Products must undergo batch testing, meet stability requirements, and have labeling in Arabic. Additionally, compliance with serialization mandates may be required to enhance product traceability and prevent counterfeit products.

3How to Approach

Frequently Asked Questions — Medica Pharmaceutical Industries L

What products does Medica Pharmaceutical Industries L import from India?

Medica Pharmaceutical Industries L imports 2 pharmaceutical products across 2 categories. Top imports: Salicylic ($167.3K), Torsemide ($97.5K).

Who supplies pharmaceuticals to Medica Pharmaceutical Industries L from India?

Medica Pharmaceutical Industries L sources from 1 verified Indian suppliers. The primary supplier is Cipla Limited (100.0% of imports, $4.9M).

What is Medica Pharmaceutical Industries L's total pharmaceutical import value?

Medica Pharmaceutical Industries L's total pharmaceutical import value from India is $264.8K, based on 7 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Medica Pharmaceutical Industries L focus on?

Medica Pharmaceutical Industries L imports across 2 categories. The largest: Combination Drugs (63.2%), Diuretics (36.8%).

Get Full Medica Pharmaceutical Industries L Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.